Effectiveness of Per-Operative Bupivicaine in Reducing Postoperative Pain at Port Site and Improving Mobility in Knee Arthoscopic Procedures

ConditionArthroscopic Surgery

Trial statusRecruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexAll

Age18-70

SponsorKhyber Teaching Hospital

About this trial

The investigator's aim is to evaluate the effectiveness of per-operative bupivacaine infiltration at arthroscopic port sites in reducing post-operative pain compared to placebo in patients undergoing knee arthroscopic procedures.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

5 ml of 0.5% bupivacaine infiltrated at each port site
Placebo

Treatment groups

60 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Khyber Teaching Hospital

Lead sponsor

Source ClinicalTrials.gov